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Endoplasmic reticulum stress and
inflammation in the central nervous system
Neil T. Sprenkle1, Savannah G. Sims1, Cristina L. Sánchez1 and Gordon P. Meares1,2*
Abstract
Persistent endoplasmic reticulum (ER) stress is thought to drive the pathology of many chronic disorders due to its
potential to elicit aberrant inflammatory signaling and facilitate cell death. In neurodegenerative diseases, the
accumulation of misfolded proteins and concomitant induction of ER stress in neurons contributes to neuronal
dysfunction. In addition, ER stress responses induced in the surrounding neuroglia may promote disease
progression by coordinating damaging inflammatory responses, which help fuel a neurotoxic milieu. Nevertheless,
there still remains a gap in knowledge regarding the cell-specific mechanisms by which ER stress mediates
neuroinflammation. In this review, we will discuss recently uncovered inflammatory pathways linked to the ER stress
response. Moreover, we will summarize the present literature delineating how ER stress is generated in Alzheimer’s
disease, Parkinson’s disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis, and highlight how ER stress and
neuroinflammation intersect mechanistically within the central nervous system. The mechanisms by which
stress-induced inflammation contributes to the pathogenesis and progression of neurodegenerative diseases
remain poorly understood. Further examination of this interplay could present unappreciated insights into the
development of neurodegenerative diseases, and reveal new therapeutic targets.
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Background
Innate immune activation has emerged as a prominent
component in the pathology of many neurodegenerative
diseases. Previously, the involvement of immunity in the
pathogenesis of neurological disorders had been greatly
underappreciated. However, within the last couple
decades we have come to realize that an aberrant inflam-
matory program within the central nervous system
(CNS) contributes to neuronal dysfunction [1]. While
inflammation is considered a beneficial physiological
response, as it promotes debris clearance and aids in tis-
sue repair, sustained inflammatory signaling overwhelms
the resolution capabilities of the CNS [2]. This, in turn,
is thought to be fundamental to the development of
harmful neuroinflammation. Brain-resident microglia
and astrocytes are the main source of inflammation in
the brain, and under pathological conditions these
dysregulated glial cells facilitate the events that promote
a neurotoxic microenvironment [3, 4]. Considering that
neurons have a limited regenerative capacity, excessive
neuronal loss in the CNS has dire consequences on
motor and cognitive function. A wealth of data now sup-
ports the hypothesis that inflammation in the CNS may
contribute to neurodegeneration by establishing a feed-
forward inflammatory loop which ultimately leads to
sustained neuronal damage [1, 2, 5, 6]. Importantly, this
likely reflects impairment of the normal mechanisms
involved in immune responses in the brain as inflamma-
tion, glial activation and even peripheral immune
infiltration are essential elements of normal tissue
homeostasis and repair [7, 8].
One of the pathological hallmarks of many neurode-
generative diseases is the accumulation of misfolded
proteins within the ER of neurons and neuroglia. In
response to ER stress, cells induce a highly conserved
cellular stress response called the unfolded protein re-
sponse (UPR) in an attempt to maintain homeostasis [9].
The UPR program orchestrates transcriptional and
translational changes in the cell to minimize stress, while
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concomitantly inducing protein quality control mecha-
nisms in an attempt to reduce protein misfolding. If
resolution fails, the temporally-regulated induction of
UPR-dependent inflammatory and apoptotic pathways
has the potential to exacerbate neuroinflammation and
compromise cell fidelity [10–13].
Accumulating evidence suggests that cells under severe
ER stress caused by various insults interfere with the im-
munosuppressive environment of the CNS [10, 11, 14].
These findings imply a heterogeneous cause linking ER
stress in neurons, microglia and astrocytes with inflamma-
tion in the progression of neurodegeneration. Novel intra-
cellular processes involved in this integrative cellular
response continue to emerge. Here, we will introduce re-
cently discovered signaling pathways associated with the
UPR and present current findings regarding how chronic
ER stress engenders neurological abnormalities. Further-
more, we will discuss how a UPR-induced inflammatory
phenotype in CNS-resident cells could promote condi-
tions responsible for impairing neuronal function.
The physiological role of the UPR
The majority of proteins destined for the secretory path-
way present a hydrophobic N-terminal signal sequence
during the initial stages of translation [15, 16]. This
amino acid sequence is recognized by the cytosolic pro-
tein signal-recognition particle, which coordinates
cotranslational translocation of the nascent polypeptide
across the ER membrane and into the ER lumen [17, 18].
Here, the unique environment of the ER lumen facilitates
the proper folding events that create a stable protein with
functional capabilities.
The ER serves as the cell’s largest calcium store owing
to the consistent active transport of calcium into the
lumen [19]. Intraluminal ER calcium is necessary for the
activation of calcium-dependent molecular chaperones,
including the ER resident glucose-regulated proteins
(GRPs), which go on to stabilize protein folding interme-
diates [20]. Furthermore, the ER lumen possesses an oxi-
dative environment which allow protein disulphide
isomerases (PDIs) to catalyze the formation of disulfide
bonds. Reduced PDIs are reoxidized by endoplasmic
reticulum oxidoreductase α (Ero1α) to allow for con-
tinuous oxidation of free cysteine residues residing on
unfolded proteins [21]. Additional post-translational
modifications, such as glycosylation, are executed within
the ER to produce a mature protein that is packaged
into coat protein complex II-coated vesicles and
exported out of the ER [22, 23]. ER-derived vesicles then
enter the canonical secretory pathway where cargo is
either targeted to the plasma membrane or to other
cellular compartments.
Features of pathophysiological stress in the form of
gene mutations, protein aggregates, inflammatory
signals, metabolic alterations, pathogen-associated mo-
lecular patterns (PAMPs), danger-associated molecular
pattern molecules (DAMPs) and/or reactive oxygen or
nitrogen species (ROS/RNS) disrupts efficient protein
folding processes in the ER lumen, thus creating an
imbalance between the protein load and the folding
capabilities of the ER [24]. The UPR responds to cellular
stress by triggering effector mechanisms that can be
grouped as adaptive, alarming or pro-apoptotic [20]. In
the adaptive phase of the UPR, mammalian cells are able
to tolerate moderate protein misfolding by upregulating
the expression of chaperone proteins to correctly fold
and stabilize the increasing amount of polypeptide trans-
ported into the ER lumen. In an effort to maintain
quality control, the cell also employs ER-associated deg-
radation (ERAD) and attenuates translation of global
messenger RNA (mRNA) to alleviate the protein load
within the lumen [25, 26]. In more severe situations, the
protein folding capacity of the ER fails to keep pace with
the increasing influx of polypeptide, as the extensive
accumulation of misfolded proteins in the ER lumen
begins to overwhelm the compensatory mechanisms of
the UPR. If improperly regulated, the buildup of
misfolded proteins will compromise normal cellular pro-
cesses. Under these conditions, the cell initiates signaling
pathways associated with cellular stress, most notably
the activation of inflammatory pathways, and ‘alarms’
the extracellular environment of the distress so that the
appropriate tissue-wide response is initiated [20]. If all
else fails the UPR will trigger cell death through both
caspase-dependent and -independent means [27–29].
Signal transducers of the ER stress response
In mammalian cells, the central proteins involved in ini-
tiating this evolutionarily conserved response are activat-
ing transcription factor 6 (ATF6), inositol-requiring 1α
(IRE-1α) and double-stranded RNA dependent protein
kinase-like ER kinase (PERK) [24]. GRP78 (also known
as binding immunoglobulin protein (BiP)) primarily
regulates the initiation of the UPR through its direct in-
teractions with each signal transducing sensor [30–32]
(Fig. 1). Physical contact between GRP78 and the
luminal domain of the ER-transmembrane proteins sta-
bilizes their inactive state. High demand for chaperone-
mediated protein stabilization brought on by increases
in protein synthesis or defective protein folding recruits
GRP78 away from these proteins [31]. Disrupting this
interaction frees the luminal domain of the ER sensors,
consequently inducing their functional conformation.
Recent evidence has suggested an additional regulatory
mechanism by which the sensors become catalytically
active. By crystallizing the yeast IRE-1, Credle et al.
elucidated a distinct peptide-binding groove in the IRE-1
luminal domain [33, 34]. In this model, unfolded
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polypeptide within the ER lumen may act as a substrate
for the peptide-binding groove located in IRE-1. Because
of the shared structural homology with that of IRE-1,
PERK may also be activated in a similar manner [33].
These findings represent a unique sensing mechanism
that regulates the activation of the UPR.
Interplay between active ATF6, IRE-1α and PERK initi-
ate signaling cascades that regulate the transcriptional
and translational landscape of the cell to selectively
promote the expression UPR-target genes. Each of these
mediators promote distinct signaling pathways which
converge to produce an effective response to mitigate
damage. If overwhelmed, these signaling proteins will
initiate apoptosis [35] (Fig. 2).
Mammalian ATF6 is a type II transmembrane protein
embedded within the ER membrane [36]. The carboxyl
terminus of ATF6 acts as the intraluminal sensor while
the amino terminus protrudes into the cytosol and func-
tions as a basic leucine zipper (bZIP) transcription factor
[37]. Dissociation of GRP78 from the luminal domain
causes ATF6 to translocate to the Golgi apparatus. Lo-
cated at the Golgi are site-1 and site-2 proteases, both of
which have been implicated in the regulation of choles-
terol metabolism [38]. It is here that ATF6 is cleaved,
resulting in the release of the bZIP transcription factor
into the cytosol [36]. From the cytosol, the processed
ATF6 fragment localizes into the nucleus and helps
upregulate the expression of genes responsible for
mediating protein folding and ERAD [36, 39].
IRE-1α is a type 1 transmembrane protein containing
an ER-sensing amino terminus, and a cytosolic carboxyl
terminal endoribonuclease (RNase) and serine-threonine
kinase domain [31, 40, 41]. Detection of unfolded pro-
teins causes IRE-1α to dimerize and/or form higher
order oligomers, which in turn activates its kinase do-
main. Subsequent trans and autophosphorylation stimu-
lates the RNase activity of IRE-1α [42]. Acquisition of
RNase catalytic activity enables for the excision of a 26-
nucleotide intron within a mature X-box-binding protein
1 (XBP1) mRNA transcript in the cytosol [43]. The
spliced XBP1 (sXBP1) mRNA encodes for an XBP1
isoform which, like ATF6, binds upstream cis-elements
associated with chaperone and ERAD-mediated genes
[39, 44]. Sustained ER stress augments the RNase activ-
ity of IRE-1α, thereby causing decreased specificity for
XBP1 mRNA and elevated degradation of specific classes
of mRNAs, 28S ribosomal RNA and microRNAs
through regulated IRE1-dependent decay (RIDD) [45].
The degradation of RNA transcripts destined for the ER
and ribosomal RNA is thought to initially help diminish
mRNA translation to alleviate the protein load on the
ER [46]. Nevertheless, prolonged RIDD activity resulting
Fig. 1 The Adaptive Signals of the Mammalian UPR. The activation of PERK, IRE-1α and ATF6 in response to protein misfolding stress primarily
requires the dissociation of the molecular chaperone GRP78 from each of the ER stress sensors. This initiates signaling cascades which orchestrate
the transcriptional and translational landscape of the cell in an effort to maintain homeostasis
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from chronic ER stress contributes to cell death by
degrading ER-targeted mRNA that encode proteins
involved in protein folding and anti-apoptotic micro-
RNA, thus pushing cell fate toward apoptosis [47–49].
Lastly, PERK possesses type 1 transmembrane top-
ology and a cytosolic kinase domain [31]. Structural
analysis has revealed that the sensing luminal domain of
PERK shares a conserved protein sequence with that of
IRE-1α [26]. Unsurprisingly, both PERK and IRE-1α
respond to ER stress in a similar manner. Along with
IRE-1α, PERK indirectly reduces the quantity of
unfolded polypeptide within the ER to allow for more
efficient chaperone-mediated protein folding in a well-
saturated ER lumen. The dimerization of PERK leads to
the activation of its cytosolic kinases, which subsequently
phosphorylate serine 51 on the α-subunit of eukaryotic
initiation factor 2α (eIF2α) [26]. Phosphorylation of eIF2α
prevents the translation of many nuclear-encoded mRNA
transcripts by compromising the formation of the GTP·eI-
F2α·Met-tRNAi ternary complex, which in turn prevents
the assembly of the pre-initiation complex at the 5′ end of
mRNA [50, 51]. Delaying translation re-initiation in this
manner increases the probability that ribosomes will scan
past inhibitory upstream open reading frames, resulting in
increased translation of a specific subset of mRNAs, most
notably mRNA that encodes ATF4 [50, 52]. Like ATF6,
ATF4 is a bZIP transcription factor important for
maintaining intracellular homeostasis through the upregu-
lation of UPR-target genes involved in efficient protein
folding, the antioxidant response and amino acid biosyn-
thesis and transport [53]. In addition to promoting an
adaptive response, ATF4 regulates the transcription of the
gene encoding pro-apoptotic factor CCAAT-enhancer-
binding protein homologous protein (CHOP) [54].
While the role of CHOP in stress-induced apoptosis
remains obscure, it is thought that CHOP promotes
apoptosis by 1) downregulating the expression of Bcl-2,
a pro-survival proto-oncogene, 2) elevating the expres-
sion of pro-apoptotic BH3-only Bcl-2 family proteins
such as Bad, Bim and p53 upregulated modulator of
apoptosis and 3) coordinating intracellular calcium sig-
naling [54, 55]. The latter relies on the involvement of
the ER. In addition to its role in mediating stable protein
folding, the ER serves an important function in cell
signaling due to its ability to release calcium in response
to second messengers. During unremitting PERK activa-
tion, CHOP accumulates to a point necessary to activate
Ero1α, which drives the aperture of the ER calcium re-
lease channel inositol 1, 4, 5-triphosphate (IP3) receptor
1 [56, 57]. Prolonged efflux of calcium from the ER pro-
motes the activation of calcium/calmodulin-dependent
protein kinase II, which plays a role in promoting cell
death [57]. Moreover, free cytosolic calcium leaks into
the mitochondrial matrix, causing mitochondrial
Fig. 2 Apoptotic Signals Associated with Chronic UPR Activation. Persistent ER stress triggers the apoptotic component of the UPR. PERK and
IRE-1α drive UPR-induced apoptosis by initiating pathways which facilitate enhanced ROS production, Ca2+ dysregulation and caspase activation
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depolarization [58]. Mitochondrial uptake of calcium re-
leased from the ER also elevates the production of ROS
through various mechanisms, including activating the
mitochondrial permeability transition and stimulating
Krebs cycle dehydrogenases [53, 58, 59]. Besides facilitat-
ing calcium release, Ero1α contributes to the production
of hydrogen peroxide within the ER lumen [60].
Along with targeting Bcl-2 family genes and Ero1α,
CHOP binds to promoter elements associated with
growth arrest and DNA damage-inducible protein 34
(GADD34). The induction of GADD34 is imperative for
attenuating signals downstream of the PERK-eIF2α-
ATF4 pathway. This GADD34-dependent negative
feedback loop relies on GADD34 recruiting protein
phosphatase 1 (PP1) to dephosphorylate eIF2α. Mutating
the conserved motifs important for binding PP1 in
GADD34 impairs eIF2α dephosphorylation, thus sup-
porting its regulatory role in mediating the phosphoryl-
ation state of eIF2α [61]. Moreover, knocking out CHOP
diminishes GADD34 protein expression, leading to
elevated levels of phosphorylated eIF2α when compared
to wild-type (WT) cells experiencing ER stress [62]. Al-
though GADD34-mediated dephosphorylation of eIF2α
is essential for cells to restore global mRNA translation
after acute insult, the overexpression of GADD34 in-
creases the translation of mRNA transcripts induced
during the later stages of prolonged ER stress, thereby
elevating the protein load and restoring global transla-
tion of proteins involved in ROS production and
apoptosis [63]. Additionally, GADD34 may have pro-
apoptotic effects that are independent of its role in
regulating eIF2α phosphorylation that contribute to ER
stress-induced cell death [62, 64].
Another downstream effector of active PERK is the
bZIP transcription factor nuclear factor-like 2 (Nrf-2),
which is important for the expression of antioxidants
[65]. Nrf-2 is normally sequestered within the cytosol by
kelch-like ECH-associated protein 1 (Keap1) under basal
states, however, the initiation of the UPR allows PERK
to act on the Nrf-2-Keap1 complex. PERK-mediated
phosphorylation of Nrf-2 promotes its dissociation from
Keap1 and translocation into the nucleus where it upre-
gulates the expression of genes essential for redox
homeostasis. Cullinan et al. demonstrated that deleting
Nrf-2 compromises the ability of mouse embryonic fi-
broblasts (MEFs) to cope with ER stress, as cells without
Nrf-2 were more susceptible to undergoing ER stress-
induced apoptosis compared to WT MEFs treated with
tunicamycin, a pharmacological ER stress-inducing agent
that blocks N-linked glycosylation [66]. The same study
also provided evidence showing that PERK phosphoryl-
ation was sufficient to disrupt the Nrf-2-Keap1 complex,
thereby allowing Nrf-2 to function as a transcription
factor independent of the presence of ROS/RNS.
During the UPR, PERK and ATF6 signaling have been
shown to upregulate the expression of sXBP1 mRNA
(through different mechanisms) to produce an operative
transcription factor responsible for inducing the expres-
sion of stress-response genes [67, 68]. Furthermore,
there is evidence that the transcription of CHOP is also
under the control of the active ATF6 transcription factor
[69]. This demonstrates that not only do the ER sensors
elicit independent signaling cascades in the face of ER
stress, but there is cross-talk between the different UPR
pathways in an effort to provide a robust response to
physiological stress. In addition to ATF6 and IRE-1α
regulating the transcription of chaperone proteins and
enzymes mediating ERAD, both have also been impli-
cated in the biosynthesis of ER phospholipids, which are
used to expand the ER membrane, and in the regulation
of other aspects of cellular metabolism [70, 71]. Interest-
ingly, components of the UPR play an essential role in
learning, memory and behavior. The eIF2α kinases, in-
cluding PERK, regulate memory and synaptic plasticity
by modulating gene expression and translation [72].
Moreover, a recent study demonstrated an important
role for XBP1 in facilitating memory and long-term
potentiation through the regulation of brain-derived
neurotrophic factor expression [73]. The involvement of
the UPR in optimizing the protein folding capacity of
the ER as well as modulating cellular metabolism and
cognitive function highlights the pleiotropic actions of
the ER stress response in maintaining tissue and organis-
mal homeostasis.
UPR-mediated inflammatory pathways
In addition to coordinating the expression of stress-
response genes during ER stress, the UPR initiates
inflammatory pathways essential for the innate immune re-
sponse (Fig. 3). The principal inflammatory signaling pro-
teins activated during the UPR are the nuclear factor
kappa-light-chain-enhancer of activated B cells (NF-κB)
and the mitogen activated protein kinase (MAPK) family
proteins c-Jun N-terminal kinase (JNK) and p38. It is im-
portant to note that NF-κB and the MAPKs regulate not
only inflammatory gene expression, but they also play a role
in mediating cell survival in a context-specific manner [74].
The NF-κB family of proteins are made up of homo-
and heterodimeric transcription factors composed of
proteins in the NF-κB/Rel family [75]. In unstressed
cells, NF-κB is sequestered within the cytosol through
physical interaction with inhibitors of κB (IκB). Signaling
through the canonical NF-κB pathway activates the
serine kinase IκB kinase (IKK), which is composed of
two catalytic subunits (IKKα and IKKβ) and a regulatory
subunit (IKKγ). Site-specific phosphorylation of IκB by
IKK signals for its degradation through the ubiquitin-
dependent recruitment of the 26S proteasome [76].
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Subsequently, free NF-κB is able to localize to the nu-
cleus and bind to κB sites in gene promoters, and drive
the expression of cytokines and cell survival proteins.
NF-κB can be activated by various forms of cell stress.
For example, in addition to ER stress, elevated levels of
cytosolic calcium and oxidative stress have been shown
to promote NF-κB-mediated transcription [77, 78]. In
the context of ER stress, the attenuation of global
mRNA translation in response to eIF2α phosphorylation
provides a means by which NF-κB is stimulated. De-
pressing mRNA translation decreases protein levels of
IκB and NF-κB within the cytosol [79]. Because IκB has
a shorter half-life than NF-κB, the higher proportion of
NF-κB to IκB favors the migration of free NF-κB into
the nucleus to upregulate the transcription of inflamma-
tory genes.
Along with PERK, IRE-1α elicits inflammatory signal-
ing during the ER stress response. After oligomerization,
IRE-1α recruits the adaptor protein tumor-necrosis
factor-α (TNF-α)-receptor-associated factor 2 (TRAF2),
which couples the activation of IRE-1α with different
inflammatory pathways. The formation of the IRE-1α-
TRAF2 complex mediates cross-talk between active IRE-
1α and the NF-κB and MAPK signaling pathways.
TRAF2 directly interacts with IKK and indirectly with
JNK by activating apoptosis signal-regulating kinase 1
(ASK1), which then coordinates the activation of JNK
[20, 80, 81]. IRE-1α-mediated activation of IKK leads to
the phosphorylation of IκB to promote NF-κB-
dependent transcriptional regulation, while the IRE-1α-
dependent activation of JNK stimulates the bZIP
transcription factor activator protein 1 (AP-1). There-
after, AP-1, a heterodimer composed of a differential
combination of Fos, Jun, ATF and Maf sub-family mem-
bers, binds to enhancer elements which upregulate the
transcription of inflammatory genes [82].
Interestingly, the IRE-1α-TRAF2 axis has been shown to
stimulate the nucleotide-binding oligomerization domain
1 and 2 (NOD1/2)-receptor-interacting serine/threonine-
protein kinase 2 (RIPK2) pathway, resulting in the activa-
tion of NF-κB [83]. This proposed mechanism was
supported in an in vivo murine model of Brucella abortus
infection. Brucella abortus induces ER stress by injecting
host cells with the VceC virulence factor via its type IV se-
cretion system. Here, Keestra-Gounder et al. demon-
strated that the resulting ER stress-induced production of
interleukin (IL)-6 in infected mice was dependent on
TRAF2, NOD1/2 and RIPK2 interplay. These findings
provided further evidence of dynamic interactions be-
tween innate immunity and UPR-induced inflammation.
Fig. 3 Inflammatory Pathways Induced by the UPR. The UPR stimulates various inflammatory pathways to alert surrounding cells of potential danger.
The transient interaction between impaired proteostasis and inflammation is considered a beneficial feature of the UPR. Nevertheless, sustained
UPR-induced inflammation is considered a pathological factor in many chronic disorders, such as neurodegenerative diseases. Inflammatory pathways
associated with the UPR include the NF-κB, JAK1/STAT3, NOD1/2-RIPK2, JNK and p38 signaling pathways
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In conjunction with its involvement in initiating
inflammation, IRE-1α can facilitate cell death through its
interactions with the apoptotic proteins during ER stress
[84]. IRE-1α-dependent activation of caspase-12 has been
reported to be a dispensable contributor in the execution
of ER stress-induced apoptosis in mice and rats [85–87].
Nevertheless, many human variants of caspase-12 possess
loss-of-function mutations that promote the synthesis of a
truncated protein without functional activity, and thus
may not be a significant contributor to ER stress-induced
cell death in humans [87]. The IRE-1α-TRAF2-JNK path-
way coordinates cell death by facilitating Bax-dependent
apoptosis and inhibiting the pro-apoptotic protein Bcl-2,
while the IRE-1α-TRAF2-p38 branch may enhance CHOP
transcriptional activity [20, 88, 89]. This understanding
highlights the importance of TRAF2 in linking the UPR to
a diverse range of signaling pathways to trigger the
appropriate physiological response.
Recently, the interaction between PERK and Janus
kinase 1 (JAK1) in the UPR was elucidated in astrocytes.
It has been recognized that ER stress influences the
JAK-signal transducers and activators of transcription
(STAT) pathway [90, 91], however, the molecular mech-
anisms underlying its involvement in the context of
neurodegeneration and how it alters the JAK-STAT
pathway in glial cells remained to be clarified. We
observed that JAK1-STAT3 signaling in ER stressed
astrocytes was dependent on PERK [92]. Transfecting
astrocytes with PERK small interfering RNA, followed
by treatment with thapsigargin, a non-competitive in-
hibitor of the sarco/endoplasmic reticulum Ca2+ ATPase
used to induce ER stress, attenuated JAK1 and STAT3
phosphorylation. Additionally, PERK knockout MEFs in-
cubated with thapsigargin expressed significantly less
phosphorylated STAT3 and STAT3-dependent inflam-
matory cytokines and chemokines relative to their WT
counterparts. Mass spectrometry revealed that JAK1
phosphorylates PERK at tyrosine 585 and 619 in vitro.
While further investigation is needed to completely un-
ravel how STAT3 is phosphorylated by the PERK/JAK1
complex, these findings present a novel pathway impli-
cating the UPR in driving neuroinflammation.
Each of the three ER stress sensors serves a multifunc-
tional role in maintaining ER protein homeostasis under
transient ER stress. If the cell is unable to ameliorate
intrinsic protein misfolding stress, the cell will induce
apoptotic pathways to avoid continuously secreting
distress signals to neighboring cells. The category of stim-
uli or environmental conditions may be an important
determinant regarding whether the cell will trigger a coor-
dinated cell death. One must also consider that certain cell
types, such as highly secretory cells, must constantly
maintain an optimal ER protein folding environment,
making them more susceptible to ER stress.
Chronic ER stress leads to the disproportionate activa-
tion of the ATF6, IRE-1α and PERK pathways to amplify
the apoptotic component of the UPR [93]. Some experi-
mental models respond to severe ER stress by attenuat-
ing ATF6 and IRE-1α signaling and augmenting PERK
activation to allow apoptotic signals to dominate [93].
Because CHOP possesses a short half-life, chronic PERK
activation is required to overwhelm the adaptive signals
of the UPR to promote cell death [94, 95]. Similarly,
sustained IRE-1α signaling has the potential to initiate
apoptosis in other situations. While various pharmaco-
logical approaches have provided invaluable insights into
the physiologic role of the UPR, more work must be
done to fully appreciate how each of the branches of the
UPR respond to specific stimuli and how they integrate
to mediate apoptotic events.
ER stress in neurodegenerative diseases
The activation of the UPR plays an essential role in
maintaining vital biological processes within the brain
during cellular stress. In fact, moderate ER stress
enhances cellular protection against subsequent insult
by altering the transcriptome and proteome of the cell
to increase the adaptive capacity of the ER, a response
called the hormetic response [9, 96–99]. However,
prolonged ER stress developed in neurodegenerative
diseases is believed to disrupt the protective mechanisms
of the UPR, leading to the activation of inflammatory
and apoptotic programs that promote neurotoxicity. In
the following sections we will briefly describe the mech-
anisms underlying how ER stress is generated in neuro-
degenerative diseases, such as Alzheimer’s disease (AD),
Parkinson’s disease (PD), Amyotrophic Lateral Sclerosis
(ALS) and Multiple Sclerosis (MS), then address its
potential contribution to the development of patho-
logical neuroinflammation. In general, ER stress is a
consequence of disturbances in protein-quality control
machinery, ER Ca2+ dysregulation, protein-trafficking
impairment or direct defects in UPR components [9].
Alzheimer’s disease
AD is a common age-dependent neurodegenerative dis-
ease that accounts for a significant number of reported
dementia cases [100]. The pathology of AD is character-
ized by the formation of intracellular neurofibrillary
tangles (NFTs) composed of hyperphosphorylated tau
and the extracellular parenchymal deposition of
amyloid-β (Aβ) aggregates [101, 102]. The cytoplasmic
protein tau normally serves to stabilize microtubules
which form ‘tracks’ that facilitate intracellular vesicle
trafficking and axonal elongation and maturation. This is
highlighted by the finding that knocking down tau leads
to severe neurite growth defects in primary cerebellar
neurons [103]. However, certain insults cause an
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imbalance between the activities of tau kinases and
phosphatases that lead to the abnormal phosphorylation
of tau [104]. In its hyperphosphorylated state, tau
becomes soluble and, in turn, polymerizes to form oligo-
mers and/or NFTs [105]. In the case for Aβ pathology,
genetic studies have implicated mutations in Aβ precur-
sor protein (APP) and in the transmembrane proteins
presenilin-1 (PS1) and presenilin-2 (PS2), which act as
subunits for the γ-secretase complex, as the predomin-
ant genetic factors contributing to the onset of familial
AD [106, 107]. Potentially pathological Aβ is liberated
when APP is sequentially cleaved at the plasma mem-
brane by β-secretase, then γ-secretase. [101]. This leads
to an extracellular accumulation of either total Aβ or in-
crease relative concentrations of amyloidogenic Aβ, such
as Aβ42. Impaired clearance of Aβ has also been impli-
cated in AD, as it creates an imbalance of its turnover in
the brain [108].
Chronic ER dysfunction is highly associated with the
memory and cognitive manifestations commonly observed
in different experimental models of AD [109, 110]. To this
point, Ma et al. elucidated that selectively abating the ex-
pression of PERK in mice possessing AD-linked mutations
in genes encoding APP and PS1 prevented the aberrant
phosphorylation of eIF2α [111]. This, in turn, improved
synaptic plasticity and spatial memory in AD mice, con-
sistent with the requirement for active protein translation
in memory consolidation [112]. Interestingly, sXBP1 over-
expression ameliorates cognitive function in the 3× Tg AD
mouse model [113]. The eIF2α kinases general control
non-derepressible 2 (GCN2) [111] and double stranded
RNA-dependent kinase (PKR) have also been implicated
in memory impairment [110, 114]. Multiple studies have
demonstrated that Aβ oligomers can activate PKR and in-
duce ER stress by eliciting the TNF-α pathway [110, 115].
Additionally, Aβ may stimulate ER Ca2+ release through
ryanodine receptors and IP3 receptors, which triggers ER
stress, neuronal apoptosis and mitochondrial fragmenta-
tion [116–118]. Inhibition of both GCN2 and PKR
through different mechanisms significantly improves cog-
nitive function in murine AD models [111, 114]. These
findings suggest that pathophysiological conditions, not
just ER stress, which lead to sustained eIF2α phosphoryl-
ation have the potential to aggravate the cognitive
abnormalities seen in AD.
Abnormal protein aggregates interfere with the normal
processes involved in protein maintenance and traffick-
ing in models of neurodegeneration. Regarding AD,
soluble tau has been shown to cause pathological ER
stress by targeting and impairing components involved
in ERAD [119]. Paradoxically, pre-existing ER stress also
promotes NFT formation. It is well known that Aβ
oligomer-dependent ER stress responses can lead to the
activation of different kinases, such as the serine/
threonine kinase glycogen synthase kinase 3 (GSK-3)
[120, 121]. This kinase (among others) is capable of sub-
sequently phosphorylating specific epitopes on tau that
contribute to the development of NFT [120, 121].
Therefore, ER stress and hyperphosphorylated tau could
be induced by each other in a cycle to propagate AD
pathology [122]. More recently, however, the correlation
between NFT formation and AD severity had been scru-
tinized [123]. It seems now that soluble oligomers of tau
and Aβ may be the primary neurotoxic agents that
contribute to AD [123].
It has been suggested that familial AD-linked PS1
mutations suppress the activation of IRE-1α. This predis-
poses cells to become more susceptible to ER stress due,
in part, to decreases in protein chaperone synthesis as a
result of reduced UPR induction [124]. A study using SK-
N-SH cells and fibroblasts expressing a PS1 mutant asso-
ciated with familial AD demonstrated that mutant PS1
also disrupts PERK activation, potentially in a similar
manner as IRE-1α, and delays nuclear accumulation of
processed ATF6 in response to ER stress [125]. The aber-
rantly spliced isoform of PS2 (PS2V) is also linked to AD.
Similar to the PS1 mutations, this isoform increases the
vulnerability of the cell to ER stress [126]. Alternatively,
the over-expression of PS1 and PS2 mutants in cells per-
turbs ER calcium homeostasis, implying another mechan-
ism by which genetic mutations in the presenilin genes
contribute to AD [127–129]. With this in mind, there is
contradictory evidence indicating that neither ablation of
PS1 or expression of familial AD-linked PS1 variants im-
pairs the expression of GRP78 mRNA and the activation
of IRE1-α [130]. Because of limited knowledge regarding
how ER stress is generated during AD, more investigation
is needed to fully appreciate how dysregulated UPR signal-
ing contributes to the pathology of AD.
Parkinson’s disease
PD is a chronic and progressive movement disorder char-
acterized by the selective loss of dopaminergic neurons in
the substantia nigra, and the presence of intraneuronal
filamentous inclusion bodies called Lewy bodies. While
the development of Lewy bodies is not a definitive causa-
tive factor, they are deemed to be a pathological hallmark
of PD. A post-mortem study showed that the percentage
of Lewy body-containing dopaminergic neurons positive
for caspase-3 is significantly higher than the percentage of
caspase-3–positive dopaminergic neurons without Lewy
bodies, indicating that Lewy body-containing dopamin-
ergic neurons are predisposed to undergo apoptosis [131].
A principal component of Lewy bodies in PD are the ab-
normal filaments of α-synuclein, which seem to form due
to different genetic factors, such as the multiplication of
the SCNA locus, or non-genetic factors, such as aberrant
post-translational modifications [132–134].
Sprenkle et al. Molecular Neurodegeneration  (2017) 12:42 Page 8 of 18
Common mutations implicated in autosomal recessive
PD reside within the Parkin gene, which encodes for an E3
ubiquitin ligase that is necessary for mitophagy [135, 136].
Studies using post-mortem brain samples and mouse
models also suggest that Parkin can be inactivated by post-
translational modifications, such as oxidation, nitrosylation
and the addition of dopamine [135]. Disrupting the E3 lig-
ase activity of Parkin or defects in PTEN-induced kinase 1,
which recruits Parkin to the outer membrane of damaged
mitochondria, is thought to play a critical role in the devel-
opment of familial and sporadic PD, mainly through its
failure to maintain mitochondrial fidelity [137]. Similarly,
mutations within the gene that encodes leucine-rich repeat
kinase 2 (LRRK2) have been shown to promote PD [138].
LRRK2 is a widely expressed protein important for regulat-
ing various biological processes. Mutant LRRK2 is highly
associated with the onset of inherited and sporadic PD,
and the resulting LRRK2-mediated toxicity may be
dependent on its kinase activity [139]. Nevertheless, the
mechanisms underlying its role in the pathogenesis of PD
are still being unraveled.
The notion that prolonged ER stress contributes to PD
pathology was first supported with the findings that neu-
rons in toxin-induced models of PD highly expressed
genes involved in the UPR [140]. It is now appreciated
that α-synuclein-induced neurotoxicity may result from
nitrosative stress, accumulation of ERAD substrates and/
or defective vesicular trafficking, all of which can lead to
ER stress [141]. To this point, under conditions of nitro-
sative stress, S-nitrosylation directly inactivates PDI
[142]. This inactivation impairs proper protein folding
and hinders PDI-mediated attenuation of neuronal cell
death [142]. Moreover, the concomitant accumulation of
toxic α-synuclein oligomers in the ER further exacer-
bates the severity of ER stress, leading to deleterious
UPR signaling [134, 143]. Some findings indicate that α-
synuclein-dependent ER stress is the result of blocking ER
to Golgi vesicular trafficking, as preventing vesicle
mobilization from the ER causes the accumulation of pro-
tein cargo within the ER lumen [144]. Targeting pathways
associated with these abnormal phenotypes through
pharmacological intervention in vitro has been shown to
rescue neuronal loss observed in PD models [141].
Post-mortem analysis revealed that human PD patients
exhibited greater phosphorylated PERK and eIF2α in
neuromelanin containing dopaminergic neurons relative
to control cases [145]. In the same study, phosphorylated
PERK colocalized with α-synuclein within dopaminergic
neurons derived from PD patients. PC12 cells possessing
the A53T mutation in the α-synuclein gene, a point
mutation that increases the tendency of α-synuclein to
form amyloid-like fibrils, exhibit elevated levels of phos-
phorylated eIF2α, CHOP, GRP78 and active caspase-12
[146]. Treatment with the caspase inhibitor z-VAD or
salubrinal, which prevents the de-phosphorylation of
eIF2α, improved cell viability of A53T PC12 cells by
attenuating apoptotic signaling [146]. Taken together,
these findings suggest that pathological α-synuclein may
exacerbate disease progression by promoting excessive
or unmitigated ER stress responses.
Stress-induced Parkin expression serves as a protective
mechanism elicited by the UPR [147, 148]. The use of
chromatin immunoprecipitation led to the discovery that
ATF4 regulates Parkin gene expression by binding to
CREB/ATF sites in the Parkin promoter [148]. The
resulting increase in Parkin protein protects against ER
stress-induced cell death in neurons by preventing the
toxic accumulation of Parkin substrates. Moreover, the
protective function of Parkin could be partially explained
with the discovery that Parkin promotes the production
of sXBP-1, which upregulates the transcription of pro-
survival genes [149]. Recent evidence indicates that
Parkin controls the function of PS1 and PS2, suggesting
a possible link between defective Parkin and the patho-
genesis of both AD and PD [150]. LRRK2 also helps
maintain neuronal integrity against induced Parkinson-
ism by alleviating the consequences of ER stress. Yuan
et al. demonstrated that LRRK2 saves neuroblastoma
cells and C. elegans dopaminergic neurons from 6-
OHDA or α-synuclein toxicity [151]. They also demon-
strated that loss of function mutations in LRRK2
compromises the expression of GRP78, resulting in the
hyperactivation of p38 and elevated neuronal death.
Collectively, impairment in these protective mechanisms
in neurons provides an alternative disturbance that
contributes to the progression of PD.
Amyotrophic lateral sclerosis
ALS is a progressive neurodegenerative disease charac-
terized by the destruction of motor neurons, which leads
to paralysis and poor patient prognosis [152]. Among
cases of ALS, 10% are considered familial, while the
remaining 90% of cases are sporadic [153]. A patho-
logical hallmark of familial ALS is the formation of
ubiquitinated cytoplasmic inclusions composed of mis-
folded superoxide dismutase-1 (SOD1) [154]. However,
defects in the SOD1 gene only account for 20% of
familial ALS cases, and 2% of sporadic cases [155, 156].
An accrual of evidence now connects mutations in genes
encoding chromosome 9 open reading frame 72 (C9orf72),
transactive response DNA binding protein 43 (TDP43), and
Fused in Sarcoma RNA-binding protein (FUS) (among
others) to ALS pathology [155, 157–159]. In all, a large pro-
portion of genetic alterations implicated in ALS promote
disease onset and progression by either perturbing protein
quality control mechanisms, RNA integrity or cytoskeletal
dynamics [155]. As in other mutations associated with
neurodegenerative diseases, ALS-associated mutations are
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expressed ubiquitously within the CNS (neurons and
surrounding neuroglia), with strong evidence that both cell-
autonomous and -nonautonomous mechanisms contribute
to the progressive loss of motor neurons [155].
Mediators associated with the UPR are upregulated in
the spinal cords of ALS patients and in mutant SOD1
transgenic mice [160–162]. For instance, CHOP is highly
expressed in motor neurons, glial cells and spinal cords
of mutant SOD1 transgenic mice [163]. A similar obser-
vation is seen in spinal cord samples of sporadic ALS
patients [163]. ERAD impairment is considered a central
mechanism by which mutant SOD1 induces ER stress in
ALS. Here, mutant SOD1 protein has been shown to
inhibit a specific component of the retro-translocation
machinery involved in ERAD called Derlin-1 by directly
interacting with its cytoplasmic C-terminus [164].
Failure to export misfolded substrates from the ER in
NSC34 cells leads to their accumulation within the ER
lumen, which promotes neuronal death by eliciting the
IRE-1-TRAF2-ASK1 pathway [164].
Increased motor neuron loss and SOD1 aggregation is
observed in SOD1G85R PERK+/− mice compared to
SOD1G85R mice fully expressing PERK [165]. Interest-
ingly, ATF4 deficiency in SOD1G85R mice exacerbates
SOD1 aggregation, but delays disease onset and reduces
the expression of pro-apoptotic genes [166]. XBP1-null
NSC34 motor neurons expressing mutant SOD1 are
more apt to clear mutant SOD1 aggregates [167]. More-
over, silencing XBP1 in vivo provides protection against
disease progression in mutant SOD1 mice [167]. Taken
together, there is contradictory evidence regarding the
protective effects of the UPR in experimental models of
ALS, suggesting that the extent to which the UPR
contributes to ALS is context-dependent.
PDI has been shown to be upregulated in SOD1G93A
ALS rats and mice [168]. Furthermore, post-mortem hu-
man brain samples exhibit greater PDI expression in
comparison to controls, implying that PDI is induced in
response to the abnormalities associated with ALS [169].
The protective role of PDI in ALS emanates from its
ability to facilitate folding of misfolded assemblies,
thereby reducing SOD1 aggregate-mediated toxicity
[169]. As seen in PD, PDI expressed in spinal cords of
ALS patients is highly S-nitrosylated [170]. Increased
RNS production has been reported in ALS, and the
resulting nitrosative stress may impair the function of
PDI through this post-translational modification [171].
Aggregates composed of mutant TDP-43, FUS or
C9orf72 also initiate the UPR program [172–174]. To
this point, overexpressing ALS-associated mutant TDP-
43 in Neuro2a neuroblastoma cells results in greater
induction of CHOP, XBP1 and ATF6 [173]. Moreover,
mutations in FUS contribute to the formation of cyto-
plasmic protein inclusions that trigger ER stress
responses in NSC34 motor neurons, and are found to
co-localize with PDI in post-mortem spinal cord samples
from ALS patients [175, 176]. Lastly, a study expressing
poly(GA) repeats in neuronal cultures, which model
ALS-associated repeat expansions in the C9orf72 gene,
contribute to neuronal death by inducing ER stress
[172]. When treated with salubrinal or the chemical
chaperone TUDCA, these neurons are rescued from ER
stress-mediated cell death, indicating that mutations in
the C9orf72 gene contribute to neurotoxicity by promot-
ing ER dysfunction [172]. Overall, these findings high-
light how pathological assemblies implicated in ALS
contribute to motor neuron loss. Even with the present
understanding that SOD1-linked mutations only account
for a relatively small proportion of ALS cases, many
studies investigating the relationship between ER stress
and ALS largely utilize animal models expressing mutant
SOD1. Therefore, it will be of importance to further
elucidate the mechanisms by which ER stress is gener-
ated in other ALS models in order to fully grasp how ER
stress aggravates ALS pathology.
Multiple sclerosis
MS is T lymphocyte-mediated autoimmune disease char-
acterized by the spatiotemporal dissemination of white
matter lesions within the CNS [177]. While the etiology of
MS remains in question, it is thought to be initiated by
autoreactive T lymphocytes that have breached the blood
brain barrier (BBB) or the blood-cerebral spinal fluid-
barrier and have mounted an autoimmune response
directed toward self-CNS antigens [178]. Autoreactive B
cells and innate immune cells, such as NK cells, have also
been reported to localize to the CNS from the periphery
during MS pathology [179]. In the early stages of MS, per-
ipheral humoral and innate immune cells accumulate in
the perivascular and ventricular spaces that separate the
blood vessels from the adjacent brain tissue, reactivated by
local antigen presenting cells and subsequently move into
the brain parenchyma to promote severe neuroinflamma-
tion [180]. These reactive immune cells release a plethora
of inflammatory mediators, including nitric oxide, ROS
and inflammatory cytokines, which impair neuronal func-
tion and activates CNS-resident astrocytes and microglia.
Together, the continuous secretion of soluble inflamma-
tory mediators promotes the development of a neurotoxic
microenvironment that facilitates demyelination, axonal
degeneration and oligodendrocyte and neuronal death.
One explanation for the development of autoreactive T
and B cells is that some viral antigens presented by major
histocompatibility complex II in the periphery or the CNS
share homology with that of myelin components. Effector
lymphocytes that enter the perivascular space are reacti-
vated by antigen presenting cells presenting myelin
peptides that share sequence and structural similarities
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with foreign-peptides [181]. This phenomenon, molecular
mimicry, is considered a potential mechanism by which
pathogens break self-immunological tolerance and induce
an autoimmune reaction. Pathogens sharing high degrees
of peptide similarity with myelin-derived peptides include
Human Herpes virus type 6 and Epstein Barr virus [182].
The inflammatory milieu brought about by infiltrating
innate immune cells and reactive T lymphocytes in the
initial stages of the disease promotes further T cell
polarization to the TH1 or TH17 subsets to amplify neur-
onal damage. From a genetic standpoint, single polymor-
phisms within specific candidate genes increase the
susceptibility of individuals to developing MS. Such
candidate genes may include genes located within the hu-
man leukocyte antigen (HLA) locus and immunological
non-HLA genes involved in central tolerance, cytokine
production and homeostatic proliferation [177].
Real time qPCR analysis of CNS tissue from MS pa-
tients has revealed that the ER stress markers ATF4,
GRP78 and CHOP are significantly upregulated in the
white matter of MS patients relative to tissue from non-
MS individuals [183]. In agreement with these findings,
a study performing detailed semiquantitative immuno-
histochemical and molecular analysis on multiple CNS
cell-types in active MS lesions found that GRP78 and
CHOP were highly upregulated in astrocytes, microglia
and oligodendrocytes [184]. The elevated expression of
UPR markers in MS lesions points toward a possible link
between impaired ER proteostasis and the development
of active lesions.
There are multiple potential events hypothesized to in-
duce ER stress during MS. Glutamate excitotoxicity is an
important mechanism that contributes to autoimmune
demyelination and lesion formation [185]. Glutamate in-
duces the expression of GRP78, and GRP78 knockdown
leads to a significant increase in excitotoxicity-induced
apoptosis [186]. This suggests that glutamate excitotoxi-
city promotes neuronal death through an ER stress-
dependent mechanism, and the upregulation of GRP78
helps neurons cope with the excessive amounts of
glutamate. In accordance, GRP78 seems to be vital for
maintaining cell survival during MS. Oligodendrocyte-
selective heterozygous deletion of GRP78 in mice in-
duced with experimental autoimmune encephalomyelitis
(EAE), an experimental model used to mimic the symp-
toms of MS, aggravates disease severity and enhances
oligodendrocyte death [187].
Hypoxia is another potential ER stress inducer that is
characteristic in, though not restricted to, MS. Histo-
logical evidence points toward a similar hypoxic-type
response in diseased tissue of MS patients, as the
hypoxia-related antigen D-110 is strongly expressed in
tissue also expressing high levels of CHOP [184]. Alter-
natively, expression of human endogenous retrovirus
(HERV) envelop proteins may contribute to the path-
ology of MS by initiating neuroinflammatory and ER
stress responses in the brain [12, 188]. For instance, the
overexpression of the HERV envelope glycoprotein
Syncytin-1 causes astrocytes to upregulate ER stress re-
sponses and the production of proinflammatory media-
tors that promote oligodendrocyte toxicity [12]. Finally,
the inflammatory environment in the CNS could trigger
ER stress in highly myelinating cells, such as oligoden-
drocytes. Due to their high demand for lipid synthesis,
mature oligodendrocytes are more susceptible to ER
stress when exposed to high levels of proinflammatory
mediators. It was previously demonstrated that inter-
feron (IFN)-γ drives ER stress and cell death in oligo-
dendrocytes both in vitro and in vivo [189]. In this same
study, mice that were haploinsufficient for PERK were
more susceptible to forced expression of IFN-γ, leading
to myelination defects and oligodendrocyte death.
Therefore, excessive neuroinflammation may induce ER
stress in myelinating cells which would not only disrupt
their ability to myelinate neuronal axons, but can also
lead to cell death.
ER stress-linked inflammation in neurodegenerative
diseases
The development of ER stress is considered an underlying
factor contributing to the clinical manifestations linked to
many neurodegenerative disorders. In addition to the dis-
eases previously described, pathological processes associ-
ated with other neuropathologies, such as prion diseases
[190–193], human immunodeficiency virus associated-
neurocognitive disorders (HAND) [193, 194] and a variety
of lysosomal storage diseases [195], promote cellular and
physiological challenges which perturb ER homeostasis. A
unifying feature of all of these diseases is the presence of
neuroinflammation [2, 196–198]. While few studies have
directly examined the interactions between ER stress and
inflammation in the CNS, there is evidence that these
processes are intimately linked [24, 199, 200].
In brain tissue, microglia and astrocytes collaborate to
mediate inflammation by integrating environmental in-
formation and carrying out an appropriate response.
Microglia are CNS-resident phagocytic cells derived
from the yolk sac. These sentinels of the CNS are the
principal innate immune cell in the brain and have a key
role in orchestrating inflammatory responses [201–203].
Astrocytes are also considered important regulators of
the CNS, as they assist in neuronal metabolism, synaptic
transmission, lay down the barriers isolating the neural
tissue of the brain and coordinate the finely-tuned
events of neuroinflammation along with microglia [3].
These glial cells possess a diverse repertoire of innate
receptors, such as scavenger receptors and pattern
recognition receptors, which allow them to augment the
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expression of inflammatory cytokines and chemokines
under metabolic stress or interaction with PAMPs or
DAMPs [204, 205].
Extracellular protein aggregates or oligomers underlie
the pathology of various neurodegenerative disorders, and
act as “danger signals” released from apoptotic or necrotic
neurons [2]. These pathological assemblies can be recog-
nized by innate immune receptors residing on neighbor-
ing glial cells [2, 206]. For example, Aβ oligomers are
perceived to act as ligands for both the TNF-α receptor
and toll-like receptor 4 [207]. Transient substrate-receptor
interaction promotes an inflammatory response that initi-
ates debris clearance via phagocytosis by microglia [2].
However, chronic exposure to these DAMPs or internal-
ization of abnormal protein aggregates alters the func-
tional properties of immunocompetent microglia and
astrocytes to promote a reactive phenotype [2, 208]. In
MS, autoreactive peripheral immune cells initiate an in-
flammatory response against myelin-derived antigen and
promote neurotoxicity not only by compromising neur-
onal integrity directly, but causing astrocytes and micro-
glia to secrete cytokines and other inflammatory
mediators that contribute to demyelination [2, 209].
While chronic ER stress in neurons largely triggers
signals to initiate apoptosis, extensive ER stress in glial
cells has the potential to promote an inflammatory
microenvironment characteristic in neurodegenerative
diseases. Consistent with the role of astrocytes in medi-
ating immunological homeostasis through its interac-
tions with other cell types, the ER stress-induced
upregulation in astrocytic inflammatory processes can
encourage an inflammatory M1-like phenotype in micro-
glia [92]. Similarly, neuronal ER stress has been shown
to be positively correlated with microglial activation in a
traumatic brain injury rat model [210]. ER stress not
only influences pathways that result in the production of
inflammatory mediators, but it also alters the respon-
siveness of cells to immunogenic stimuli. To this point,
it has been documented that the administration of both
prostaglandin E2 and IFN-γ synergizes with ER stress to
increase the production of IL-6 in glial cells [211]. Like-
wise, TNF-α autocrine signaling during ER stress signifi-
cantly enhances the apoptotic signals of the UPR [80].
PERK knockdown experiments suggest that the associ-
ation between ER stressed astrocytes and microglia
activation is initially dependent on PERK signaling in as-
trocytes [92]. PERK haploinsufficiency and partial PERK
inhibition using the small molecule PERK inhibitor
GSK2606414 selectively attenuates the production of ER
stress-induced inflammatory cytokines and chemokines,
including IL-6, C-C Motif Chemokine Ligand (CCL)2
and CCL20 [212]. Interestingly, treating ER stressed as-
trocytes with ISRIB, a compound which reverses the
translational block of phosphorylated eIF2α, attenuates
ER stress-induced inflammatory gene expression [212].
We propose that the inflammatory signals induced dur-
ing ER stress in astrocytes significantly relies on PERK-
dependent eIF2α phosphorylation. These beneficial
outcomes of PERK-eIF2α modulation fall in line with
previous studies demonstrating that treating prion-
diseased mice with GSK2606414 or ISRIB confers neuro-
protection by partially recovering global translation rates
[213, 214]. Conversely, preventing eIF2α de-
phosphorylation in response to tramatic brain injury
using salubrinal is beneficial and attenuates neuroinflam-
mation [11]. While it is becoming clear that PERK
signaling has an important role in the regulation of
neuroinflammation and neurodegeneration, a more
complete understanding of the PERK-eIF2α pathway is
needed to define the context and cell-specific roles. There-
fore, manipulating the PERK-eIF2α axis without disturbing
its homeostatic function could present an unappreciated
way to alleviate aberrant neuroinflammation.
Conclusion
Many fundamental questions remain regarding the role
of inflammation and ER stress in neurological diseases.
Is inflammation beneficial or detrimental in neurodegen-
erative diseases? Most likely that it is important for
tissue repair and neural regeneration, but detrimental
when dysregulated. To complicate matters, the UPR sys-
tem may be helpful or harmful depending on the level
and spatial-temporal occurrence of ER stress. Cross-talk
between the two programs may have beneficial functions
through reciprocal regulation that promotes protective
immunity. However, ER stress-induced amplification of
inflammation may worsen chronic diseases [215].
Our understanding on if and how ER stress directly
provokes an inflammatory reaction in neurodegenerative
diseases remains to be clarified. Studies from our labora-
tory demonstrate that ER stress generated in murine
astrocytes encourages PERK-dependent inflammatory
signaling in vitro, suggesting that astrocytes themselves
are potential contributors to neurotoxic inflammation in
the face of ER dysfunction [92, 212]. Nevertheless, the
relevance of these findings as it pertains to animal
models and patients remains to be determined. Further,
whether microglia respond to ER stress in the same vain
has yet to be explored. Investigators must be cognizant
of how agents used to manipulate the UPR will impinge
on its homeostatic roles when devising pharmacological
approaches to treat neurodegenerative diseases. More-
over, since both defective and chronic UPR signaling
contribute to neuronal death in disease, developing
agents which strictly attenuate pathways elicited by the
ER stress response are insufficient. It is likely that target-
ing specific signaling components of the UPR that are
predicted to enhance the pro-survival signals of the UPR
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or attenuate its inflammatory/apoptotic responses will
possess more favorable outcomes.
In summary, ER stress and neuroinflammation are com-
mon pathological features of neurodegenerative diseases,
and the mechanisms by which they interact during neuro-
degeneration remain to be elucidated. Further knowledge
of this cross-talk will help us understand whether targeting
cell stress pathways, such as ER stress in neurodegenera-
tion, can control aberrant neuroinflammation and treat
neurological disorders. To date, many studies have demon-
strated beneficial effects of modulating ER stress pathways
either genetically or pharmacologically in model organisms.
However, the looming question remains: will targeting the
UPR pathways be safe and beneficial in patients?
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